ACADIA PHARMACEUTICALS INC — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
EFFECT
POS AM
PRE 14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | PRIMARY DOCUMENT | 0001012975-05-000229 | Aug 2, 2005 | Jul 29, 2005 |
| 4 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-031872 | Jun 14, 2005 | Jun 10, 2005 |
| 4 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-031849 | Jun 14, 2005 | Jun 10, 2005 |
| 4 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-031847 | Jun 14, 2005 | Jun 10, 2005 |
| 4 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-031842 | Jun 14, 2005 | Jun 10, 2005 |
| 4 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-031886 | Jun 14, 2005 | Jun 10, 2005 |
| 4 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-031878 | Jun 14, 2005 | Jun 10, 2005 |
| 4 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-031950 | Jun 14, 2005 | Jun 10, 2005 |
| 424B3 | PROSPECTUS FILED PURSUANT TO RULE 424(B)(3) | 0001193125-05-121560 | Jun 7, 2005 | — |
| S-3/A | AMENDMENT NO. 1 TO FORM S-1 ON FORM S-3 | 0001193125-05-118308 | Jun 1, 2005 | — |
| 10-Q | FORM 10-Q | 0001193125-05-107211 | May 13, 2005 | Mar 31, 2005 |
| 8-K | FORM 8-K | 0001193125-05-104105 | May 11, 2005 | — |
| REGDEX | AUTO-GENERATED PAPER DOCUMENT | 9999999997-05-023854 | May 10, 2005 | — |
| S-1 | FORM S-1 | 0001193125-05-101164 | May 10, 2005 | — |
| SC 13D | SCHEDULE 13D | 0000947871-05-000915 | May 2, 2005 | — |
| SC 13D | SCHEDULE 13D | 0000947871-05-000914 | May 2, 2005 | — |
| SC 13D | SCHEDULE 13D | 0000947871-05-000916 | May 2, 2005 | — |
| DEF 14A | DEFINITIVE NOTICE AND PROXY STATEMENT | 0001193125-05-090374 | Apr 29, 2005 | Jun 10, 2005 |
| SC 13D | SC 13D | 0001104659-05-019251 | Apr 29, 2005 | — |
| 8-K | FORM 8-K | 0001193125-05-089947 | Apr 29, 2005 | Apr 27, 2005 |
| 3 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-022681 | Apr 28, 2005 | Apr 27, 2005 |
| 4 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-022683 | Apr 28, 2005 | Apr 27, 2005 |
| SC 13G | — | 0000909518-05-000277 | Apr 26, 2005 | — |
| SC 13G/A | FORM 13G HOLDINGS REPORT | 0001172661-05-000115 | Apr 22, 2005 | — |
| 4 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-021853 | Apr 22, 2005 | Apr 20, 2005 |
| 4 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-021852 | Apr 22, 2005 | Apr 20, 2005 |
| 4 | PRIMARY DOCUMENT | 0001140484-05-000010 | Apr 21, 2005 | Apr 20, 2005 |
| 8-K | FORM 8-K FOR ACADIA PHARMACEUTICALS INC. | 0001193125-05-080549 | Apr 20, 2005 | Apr 15, 2005 |
| 10-K | FOR THE FISCAL YEAR ENDED DECEMBER 31, 2004 | 0001193125-05-055069 | Mar 18, 2005 | Dec 31, 2004 |
| 4 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-015859 | Mar 15, 2005 | Mar 11, 2005 |
| 4 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-015858 | Mar 15, 2005 | Mar 11, 2005 |
| 4 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-015857 | Mar 15, 2005 | Mar 11, 2005 |
| 4 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-015860 | Mar 15, 2005 | Mar 11, 2005 |
| 4 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-015861 | Mar 15, 2005 | Mar 11, 2005 |
| 4 | MAIN DOCUMENT DESCRIPTION | 0001209191-05-015862 | Mar 15, 2005 | Mar 11, 2005 |
| 8-K | FORM 8-K | 0001193125-05-041674 | Mar 3, 2005 | — |
| SC 13G | DOC ONE | 0000902219-05-000634 | Feb 14, 2005 | — |
| SC 13G/A | SC 13G/A | 0001104659-05-006278 | Feb 14, 2005 | — |
| SC 13G/A | — | 0000898432-05-000161 | Feb 11, 2005 | — |
| REGDEX | AUTO-GENERATED PAPER DOCUMENT | 9999999997-05-003650 | Jan 24, 2005 | — |
| SC 13G | SC 13G | 0001104659-05-001913 | Jan 20, 2005 | — |
| 8-K | FORM 8-K | 0001193125-05-006672 | Jan 14, 2005 | Jan 10, 2005 |
| 4 | PRIMARY DOCUMENT | 0001179044-04-000313 | Nov 29, 2004 | Nov 24, 2004 |
| 3 | PRIMARY DOCUMENT | 0001179044-04-000312 | Nov 29, 2004 | Nov 24, 2004 |
| 10-Q | FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2004 | 0001193125-04-195265 | Nov 12, 2004 | Sep 30, 2004 |
| 8-K | FORM 8-K | 0001193125-04-192811 | Nov 10, 2004 | — |
| SC 13G | SCHEDULE 13G (ORBIMED CAPITAL LLC) | 0000947871-04-002107 | Sep 3, 2004 | — |
| SC 13G | SCHEDULE 13G (ORBIMED ADVISORS LLC) | 0000947871-04-002106 | Sep 3, 2004 | — |
| SC 13G | SCHEDULE 13G (SAMUEL ISALY) | 0000947871-04-002108 | Sep 3, 2004 | — |
| SC 13G | — | 0000898432-04-000679 | Aug 30, 2004 | — |